These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25612157)

  • 1. Pharmacokinetics of Gd(DO3A-Lys) and MR imaging studies in an orthotopic U87MG glioma tumor model.
    Chandrasekharan P; Yang CT; Nasrallah FA; Tay HC; Chuang KH; Robins EG
    Contrast Media Mol Imaging; 2015; 10(3):237-44. PubMed ID: 25612157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
    Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG
    Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new polysaccharide macromolecular contrast agent for MR imaging: biodistribution and imaging characteristics.
    Helbich TH; Gossman A; Mareski PA; Radüchel B; Roberts TP; Shames DM; Mühler M; Turetschek K; Brasch RC
    J Magn Reson Imaging; 2000 Jun; 11(6):694-701. PubMed ID: 10862070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental trials with Gd(DO3A)--a nonionic magnetic resonance contrast agent.
    Runge VM; Kaufman DM; Wood ML; Adelman LS; Jacobson S
    Int J Rad Appl Instrum B; 1989; 16(6):561-7. PubMed ID: 2606711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow clearance gadolinium-based extracellular and intravascular contrast media for three-dimensional MR angiography.
    Bremerich J; Colet JM; Giovenzana GB; Aime S; Scheffler K; Laurent S; Bongartz G; Muller RN
    J Magn Reson Imaging; 2001 Apr; 13(4):588-93. PubMed ID: 11276103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium Complex of 1,4,7,10-Tetraazacyclododecane-1,4,7-trisacetic Acid (DO3A)-Ethoxybenzyl (EOB) Conjugate as a New Macrocyclic Hepatobiliary MRI Contrast Agent.
    Baek AR; Kim HK; Park S; Lee GH; Kang HJ; Jung JC; Park JS; Ryeom HK; Kim TJ; Chang Y
    J Med Chem; 2017 Jun; 60(12):4861-4868. PubMed ID: 28530407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
    Chandrasekharan P; Yong CX; Poh Z; He T; He Z; Liu S; Robins EG; Chuang KH; Yang CT
    Biomaterials; 2012 Dec; 33(36):9225-31. PubMed ID: 23026708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
    Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
    Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First in vivo MRI assessment of a self-assembled metallostar compound endowed with a remarkable high field relaxivity.
    Livramento JB; Weidensteiner C; Prata MI; Allegrini PR; Geraldes CF; Helm L; Kneuer R; Merbach AE; Santos AC; Schmidt P; Tóth E
    Contrast Media Mol Imaging; 2006; 1(1):30-9. PubMed ID: 17193598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI.
    Beaumont M; Lemasson B; Farion R; Segebarth C; Rémy C; Barbier EL
    J Cereb Blood Flow Metab; 2009 Oct; 29(10):1714-26. PubMed ID: 19584891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Relaxometric Characterization of New Poly[N,N-bis(3-aminopropyl)glycine] (PAPGly) Dendrons Gd-Based Contrast Agents and Their in Vivo Study by Using the Dynamic Contrast-Enhanced MRI Technique at Low Field (1 T).
    Granato L; Longo D; Boutry S; Vander Elst L; Henoumont C; Aime S; Muller RN; Laurent S
    Chem Biodivers; 2019 Nov; 16(11):e1900322. PubMed ID: 31544357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography.
    de Haën C; Anelli PL; Lorusso V; Morisetti A; Maggioni F; Zheng J; Uggeri F; Cavagna FM
    Invest Radiol; 2006 Mar; 41(3):279-91. PubMed ID: 16481911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
    Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
    Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization, and relaxation studies of Gd-DO3A conjugate of chlorambucil as a potential theranostic agent.
    Kaur J; Tsvetkova Y; Arroub K; Sahnoun S; Kiessling F; Mathur S
    Chem Biol Drug Des; 2017 Feb; 89(2):269-276. PubMed ID: 28205399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular imaging of angiogenesis to delineate the tumor margins in glioma rat model with endoglin-targeted paramagnetic liposomes using 3T MRI.
    Qiu LH; Zhang JW; Li SP; Xie C; Yao ZW; Feng XY
    J Magn Reson Imaging; 2015 Apr; 41(4):1056-64. PubMed ID: 24677456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, conjugation and relaxation studies of gadolinium(III)-4-benzothiazol-2-yl-phenylamine as a potential brain specific MR contrast agent.
    Saini N; Varshney R; Tiwari AK; Kaul A; Allard M; Ishar MP; Mishra AK
    Dalton Trans; 2013 Apr; 42(14):4994-5003. PubMed ID: 23389482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new gadolinium-based contrast agent for magnetic resonance imaging of brain tumors: kinetic study on a C6 rat glioma model.
    Fonchy E; Lahrech H; François-Joubert A; Dupeyre R; Benderbous S; Corot C; Farion R; Rubin C; Décorps M; Rémy C
    J Magn Reson Imaging; 2001 Aug; 14(2):97-105. PubMed ID: 11477666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.